Radiotherapy or Observation of Liver Metastases in Small Cell Lung Cancer

Trial Details

NCT ID

NCT05150145

Phase

NA

Sponsor

Guizhou Medical University

Status

RECRUITING

Cancer Type

Lung Cancer

Interventions

• Radiotherpy will be performed to thoracic and liver metastasis after chemotherapy.

Locations (sample)

• Guiyang, Guizhou, China|26.58333,106.71667

Key Eligibility Criteria

• Informed consent (radiation, medication) before treatment;
• Age 18 to 70 years old,regardless of gender;
• Initial SCLC confirmed by histopathological or cytological examination;
• Metastatic lesions in the distant area: included liver metastasis；

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.